Clinical Trial

MOTHER3SENSE Study

Study acronym: MOTHER3SENSE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to compare the effects of maternal voice, touch, and scent on pain and stress levels in newborns during a routine heel lance procedure. Newborns will be randomly assigned to one of three intervention groups or a control group. Pain and stress responses will be assessed using validated neonatal pain and physiological measures. The findings of this study may help identify effective, low-cost, and non-pharmacological interventions that can be used to reduce pain and stress in newborns during routine clinical procedures.
Trial Details
NCT Number NCT07651592
Lead Sponsor Kilis 7 Aralik University
Conditions Neonatal Pain, Stress, Psychological
Enrollment 120 participants
Start Date 2026-07-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-16